Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mercaptopurine favoured over mesalazine for patients with Crohn's disease that relapse within 3 months of surgery

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Mercaptopurine favoured over mesalazine for patients with Crohn's disease that relapse within 3 months of surgery. Pharmacoecon. Outcomes News 322, 5–6 (2001). https://doi.org/10.1007/BF03269494

    Download citation

    Keywords

    • Mesalazine
    • Mercaptopurine
    • Canadian Dollar
    • Unpaid Labour
    • Hourly Wage Rate